Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche and coordinator of EU-AIMS.
Will Spooren
Head of behavioral pharmacology and preclinical imaging
F. Hoffmann-La Roche
From this contributor
Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
Questions for Will Spooren: Paving a path to autism drugs
Explore more from The Transmitter
Remembering Avis H. Cohen, who bridged disciplines to decode lamprey locomotion
The founding director of the University of Maryland’s Neuroscience and Cognitive Science program brought neuroscience, math and engineering together.
Remembering Avis H. Cohen, who bridged disciplines to decode lamprey locomotion
The founding director of the University of Maryland’s Neuroscience and Cognitive Science program brought neuroscience, math and engineering together.
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University Medical Center through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
When autistic kids grow up, Chapter 4: How did things unfold?
Tempest McDonald sues Vanderbilt University Medical Center through the Equal Employment Opportunity Commission. Her published NIH paper finds allies.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.
NeuroDev study maps previously unseen genetic variation in Africa
The project is helping to fill critical gaps in the genetic underpinnings of autism and other neurodevelopmental conditions.